Clik here to view.
Nobel Laureate Zinkernagel Delivers Keynote Speech at NCKU
TAINAN, Taiwan National Cheng Kung University (NCKU) hosted the 2013 International Symposium on Infectious Disease and Signal Transduction together with the 2013 Taiwan-Japan Joint Symposium on Cell...
View ArticleClik here to view.
DiagCor to Launch Natera’s Panorama™ Non-Invasive Prenatal Test in Hong Kong
SAN CARLOS, Calif. Natera today announced that DiagCor, a manufacturer of in-vitro diagnostic products and service provider of clinical diagnostic tests, has signed an agreement to launch Natera’s...
View ArticleClik here to view.
Biogen Idec and Samsung Bioepis Announce Agreement to Market Anti-TNF...
CAMBRIDGE, Mass. & SEOUL, Korea Biogen Idec (NASDAQ: BIIB) and Samsung Bioepis today announced that through their joint venture, Biogen Idec has exercised its right to enter into an agreement to...
View ArticleClik here to view.
Roche and Genentech Acquire Unlimited Access to Open Monoclonal Technology’s...
PALO ALTO, Calif. Open Monoclonal Technology, Inc. (OMT), an innovator in transgenic research for discovery of human therapeutic antibodies, today announced that Genentech, a member of the Roche...
View ArticleClik here to view.
DxTerity’s REDI-Dx Wins 2013 NCT CBRNe Product of the Year Award
LOS ANGELES DxTerity Diagnostics announced that REDI-Dx™, the company’s blood-based gene expression test for estimating individualized levels of radiation exposure,* was named the 2013 NCT CBRNe...
View ArticleClik here to view.
Menicon, Azabu University, and Yokohama City University Identify the Glaucoma...
NAGOYA, Japan Menicon announces that an article entitled, “Dogs and humans share a common susceptibility gene SRBD1 for glaucoma risk”, which presents the results of a study conducted by Menicon,...
View ArticleClik here to view.
Menicon、麻布大学和横滨市立大学发现犬类青光眼易感基因SRBD1
日本名古屋 (美国商业资讯)–Menicon宣布，一篇题为“犬类的青光眼风险易感基因SRBD1与人类相同”的论文已发表于科学期刊PLoS ONE，该论文呈报了Menicon、麻布大学和横滨市立大学开展的一项研究（以下称“该研究”）的结果。 Menicon与麻布大学和横滨市立大学合作开展的研究发现，日本柴犬的青光眼易感基因与人类相同。...
View ArticleClik here to view.
Promega ViaFect™ Transfection Reagent Delivers High Performance Transfection...
Smart Multimedia Gallery ViaFect(TM) Transfection Reagent offers high performance transfection in a diversity of cell lines and iPSC-derived tissue cells. (Photo: Business Wire) View and Share Photo...
View ArticleClik here to view.
Terumo BCT Exclusive Therakos Inc. Distributor
LAKEWOOD, Colo. Terumo BCT, a global leader in blood component, therapeutic apheresis and cellular technologies, has entered into a business relationship with Therakos, Inc., a global leader in...
View ArticleClik here to view.
BioTime, Inc. Subsidiary OncoCyte Corporation Initiates Clinical Development...
ALAMEDA, Calif. BioTime, Inc. (NYSE MKT: BTX) and its subsidiary OncoCyte Corporation today announced that OncoCyte has initiated clinical development of its bladder cancer diagnostic test in both...
View ArticleClik here to view.
Quantum Biosystems Demonstrates First Reads Using Quantum Single Molecule...
OSAKA, Japan Quantum Biosystems today announced the release of raw data access to its first reads. The company released reads showing an accuracy of more than 99% in non-homopolymer regions and...
View ArticleClik here to view.
Quantum Biosystems展示采用单分子测序技术的首批读数
日本大阪 (美国商业资讯)–Quantum Biosystems今天公布了其首批读数的原始数据。该公司发布的读数显示，非均聚物区域的准确率超过99%，均聚物插入缺失区准确率约为10%。此次发布使研究人员能够评估该平台，并参与该平台的验证和开发。它标志着DNA的单分子电子测序领域的一次重大里程碑。 无需试剂的硅测序仪有望实现极低成本 Quantum...
View ArticleClik here to view.
Clik here to view.
Biogen Idec and UCB Enter Agreements to Commercialize Multiple Sclerosis and...
CAMBRIDGE, Mass. & BRUSSELS, Belgium Biogen Idec (NASDAQ: BIIB) and UCB (Euronext: UCB) announced today that they have signed exclusive agreements granting UCB the right to commercialize Biogen...
View ArticleClik here to view.
Agilent Technologies Supports Inaugural Singapore–South Korea Symposium on...
SANTA CLARA, Calif. Agilent Technologies Inc. (NYSE: A) today announced support for the inaugural Singapore-South Korea Symposium on Glycomics, where scientists and researchers from both nations...
View ArticleClik here to view.
Novogene Acquires an Illumina HiSeq X Ten Sequencing System
SAN DIEGO Illumina, Inc. (NASDAQ:ILMN) today announced that Novogene (www.novogene.cn), a leading genomics service provider based in Beijing, China, purchased one HiSeq X Ten. This strategic...
View ArticleClik here to view.
Solentim Expands Reach into China
BOURNEMOUTH, United Kingdom Solentim, the developer of imagers for single cell cloning and tools for shortening the upstream cell line development workflow, is pleased to announce that it has...
View ArticleClik here to view.
パスウェイ・ゲノミクスが遺伝性大腸がん遺伝子検査を開始
サンディエゴ （ビジネスワイヤ） — 米サンディエゴに拠点を置き、CLIAおよびCAPの認定を受けて遺伝子検査サービスを世界規模で提供している臨床ラボラトリーのパスウェイ・ゲノミクス・コーポレーションは本日、当社の優良遺伝性がん遺伝子検査サービス「遺伝性大腸がんDNAインサイト（Hereditary Colorectal Cancer DNA...
View ArticleClik here to view.
Pathway Genomics上市遗传性结直肠癌基因检测
圣迭戈 (美国商业资讯)–Pathway Genomics Corporation是经过CLIA和CAP认证的临床实验室，总部位于圣迭戈，为全球提供基因检测服务，该公司今天宣布上市遗传性结直肠癌DNA InsightSM，这是该公司的首款遗传性癌症基因检测。该检测采用下一代测序(NGS)技术，只需一份简单的唾液样本，即可检出基因变化或突变，这些变化或突变可增高患者罹患某些类型癌症的风险。...
View ArticleClik here to view.
Pathway Genomics下一代测序系统Illumina MiSeqDx获 FDA认证
圣迭戈 （美国商业资讯） — Pathway Genomics公司位于圣迭戈 ，是一家获 CLIA和 CAP认证的临床实验室，可为全球提供基因测试服务。Pathway Genomics今天宣布 Illumina MiSeqDx正式成为其下一代测序系统的一员。 通过对临床市场的设计和验证，该台式测序系统将优化公司在开发和诊断应用方面的能力。该系统...
View Article